Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number1311
Number of pages12
JournalInternational journal of molecular sciences
Volume19
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • advanced glycation endproducts
  • pyridoxamine
  • glyoxalase-1
  • experimental autoimmune encephalomyelitis
  • multiple sclerosis
  • EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
  • END-PRODUCTS AGES
  • CEREBROSPINAL-FLUID
  • INSULIN-RESISTANCE
  • METHYLGLYOXAL
  • METABOLISM
  • DISEASE
  • PLASMA
  • SYSTEM
  • MICE

Cite this